(Q53250090)

12 May 2018

title

Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin. (English)

1 reference

12 May 2018

1 reference

4

1 reference

12 May 2018

Lawrence W. Chamley

5

1 reference

12 May 2018

Christina S Han

object named as

Christina S Han

3

0 references

author name string

Tamara Y Carroll

1

1 reference

12 May 2018

Melissa J Mulla

2

1 reference

12 May 2018

Ian Giles

6

1 reference

12 May 2018

Charis Pericleous

7

1 reference

12 May 2018

Anisur Rahman

8

1 reference

12 May 2018

Anna K Sfakianaki

9

1 reference

12 May 2018

Michael J Paidas

10

1 reference

12 May 2018

Vikki M Abrahams

11

1 reference

12 May 2018

publication date

4 May 2011

1 reference

12 May 2018

American Journal of Reproductive Immunology

published in

1 reference

12 May 2018

volume

66

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

286-296

1 reference

12 May 2018

Systemic lupus erythematosus

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

New facet of antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Antiphospholipid syndrome: obstetric diagnosis, management, and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Long-term mortality after preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Placental pathology in systemic lupus erythematosus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Heparin prevents programmed cell death in human trophoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Synthesis of beta2 glycoprotein 1 by the human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Pathophysiology of the clinical manifestations of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Is interleukin-3 important in antiphospholipid antibody-mediated pregnancy failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Establishment and characterization of first trimester human trophoblast cells with extended lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

TLR6 modulates first trimester trophoblast responses to peptidoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Angiogenesis in implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Antiphospholipid antibodies affect human endometrial angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Antibodies to serine proteases in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Lipopolysaccharide from Escherichia coli induces the expression of vascular endothelial growth factor via toll-like receptor 4 in human limbal fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

TLR4 mediates LPS-induced VEGF expression in odontoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Activation of toll-like receptor 4 modulates vascular endothelial growth factor synthesis through prostacyclin-IP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Novel PKC signaling is required for LPS-induced soluble Flt-1 expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

TLR2 is one of the endothelial receptors for beta 2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Effect of heparin and fractionated heparin on trophoblast invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Solution structure of the heparin-binding domain of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

Arterial and venous thrombosis is associated with different angiogenic cytokine patterns in patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2011.01007.X

10.1111/J.1600-0897.2011.01007.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018